(iii) Expanding beyond MLH1 and MSH2 genes would enhance generalizability across diverse genetic backgrounds, e.g., confirmed PV in the MSH6 and PMS2 genes, would expand our understanding of cancer manifestation variability across all relevant MMR genes. The gene discussed is MSH2; the disease is cancer.